Entrada Therapeutics Inc (TRDA)

Nov 17, 2024

Los Angeles Capital Management LLC Purchases Shares of 33,932 Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Entrada Therapeutics stock hits 52-week high at $20.28 By Investing.com - Investing.com UK

Nov 13, 2024

Nov 11, 2024

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 11, 2024

Nov 10, 2024

HC Wainwright Issues Positive Forecast for Entrada Therapeutics (NASDAQ:TRDA) Stock Price - Defense World

Nov 10, 2024

Nov 08, 2024

HC Wainwright Analysts Boost Earnings Estimates for TRDA - MarketBeat

Nov 08, 2024

Nov 08, 2024

Entrada Therapeutics (NASDAQ:TRDA) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

Nov 08, 2024

Nov 07, 2024

Entrada Therapeutics president sells shares worth $339,280 By Investing.com - Investing.com Australia

Nov 07, 2024

Nov 06, 2024

Beyond The Numbers: 4 Analysts Discuss Entrada Therapeutics Stock - Benzinga

Nov 06, 2024

Nov 06, 2024

Oppenheimer Issues Positive Forecast for Entrada Therapeutics (NASDAQ:TRDA) Stock Price - MarketBeat

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics stock target increased on positive trial data By Investing.com - Investing.com UK

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics (NASDAQ:TRDA) Price Target Raised to $20.00 - MarketBeat

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Entrada Therapeutics’ Q3 2024 Financial Highlights - TipRanks

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics (NASDAQ:TRDA) Hits New 12-Month HighHere's What Happened - MarketBeat

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics stock hits 52-week high at $18.22 By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics : Corporate Presentation - Marketscreener.com

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 05, 2024

Nov 02, 2024

Here's Why Momentum in Entrada Therapeutics (TRDA) Should Keep going - MSN

Nov 02, 2024

Oct 28, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Short Interest Down 19.1% in October - MarketBeat

Oct 28, 2024

Oct 28, 2024

Short Interest in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Declines By 19.1% - Defense World

Oct 28, 2024

Oct 19, 2024

Here's What Could Help Entrada Therapeutics (TRDA) Maintain Its Recent Price Strength - MSN

Oct 19, 2024

Oct 19, 2024

Entrada Therapeutics president sells $10,800 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Natarajan Sethuraman Sells 600 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock - MarketBeat

Oct 18, 2024

Oct 17, 2024

There Is A Reason Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Price Is Undemanding - Simply Wall St

Oct 17, 2024

Oct 15, 2024

Oppenheimer Initiates Coverage of Entrada Therapeutics (TRDA) with Outperform Recommendation - MSN

Oct 15, 2024

Oct 14, 2024

(TRDA) Trading Report - Stock Traders Daily

Oct 14, 2024

Oct 14, 2024

The Manufacturers Life Insurance Company Purchases 2,146 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Oct 14, 2024

Oct 10, 2024

Renaissance Technologies LLC Invests $636,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Oct 10, 2024

Oct 09, 2024

Entrada Therapeutics advances Duchenne treatment trials - Investing.com

Oct 09, 2024

Oct 09, 2024

Entrada Therapeutics advances Duchenne treatment trials By Investing.com - Investing.com UK

Oct 09, 2024

Oct 09, 2024

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society - The Manila Times

Oct 09, 2024

Oct 03, 2024

(TRDA) Trading Advice - Stock Traders Daily

Oct 03, 2024

Oct 01, 2024

Morguard Un (MRT-UN-T) QuotePress Release - The Globe and Mail

Oct 01, 2024

Oct 01, 2024

Pompe Disease Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Market Dynamics, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas - The Globe and Mail

Oct 01, 2024

Oct 01, 2024

Entrada Therapeutics COO sells shares worth over $13,000 - Investing.com India

Oct 01, 2024

Oct 01, 2024

Entrada Therapeutics COO sells shares worth over $13,000 By Investing.com - Investing.com Australia

Oct 01, 2024

Sep 30, 2024

Insider Sale: President & COO Nathan Dowden Sells Shares of Entr - GuruFocus.com

Sep 30, 2024

Sep 27, 2024

Entrada Therapeutics (NASDAQ:TRDA) Trading 4.8% Higher - MarketBeat

Sep 27, 2024

Sep 25, 2024

U.S. Gold Corp (USAU-Q) QuotePress Release - The Globe and Mail

Sep 25, 2024

Sep 24, 2024

Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development - Markets Insider

Sep 24, 2024

Sep 24, 2024

Entrada Therapeutics appoints new President of R&D - Investing.com

Sep 24, 2024

Sep 23, 2024

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Sep 23, 2024

Sep 23, 2024

30 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Itau Unibanco Holding S.A. - Defense World

Sep 23, 2024

Sep 23, 2024

STERIS plc (NYSE:STE) Shares Sold by XTX Topco Ltd - Defense World

Sep 23, 2024